ArticleACS applied materials & interfaces2026
Dopamine-Mediated Attenuation of OECT-Based Aqueous Artificial Chemical Synapses.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial synaptic electronic devices capable of chemical communication effectively emulate the functions and behaviors of biological synapses, making them indispensable for constructing neuromorphic computing systems and biomedical interfaces. Although many artificial synapses modulated by neurotransmitters and biomolecules have been developed, the attenuation of inhibitory and excitatory synaptic responses induced by these chemicals, which is indispensable for regulating biological nervous systems, has rarely been reported. Herein, we report an artificial synapse based on a floating-gate organic electrochemical transistor (OECT) in which dopamine attenuates various synaptic behaviors in an aqueous environment. By utilizing a floating-gate structure and an ionic gel as the primary electrolyte, our device exhibits characteristic inhibitory and excitatory synaptic behaviors. When dopamine is added to the secondary aqueous electrolyte, its dopaminergic oxidation further dedopes the floating gate, leading to the observed reduction in synaptic modulation. This study provides a practical approach to achieving chemically modulated synaptic behavior, contributing to the design of biointerfaced neuromorphic components.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.